Sustained response to open-label venlafaxine in drug-resistant major depression / Isaac Schweitzer en Journal of Clinical Psychopharmacology, Año 2001 - Vol. 21 - No. 2 (Abril)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2001 - Vol. 21 - No. 2 (Abril) . - pp. 185-189 Título : Sustained response to open-label venlafaxine in drug-resistant major depression Tipo de documento: texto impreso Autores: Isaac Schweitzer, Autor ; Graham AO, Burrows, Autor ; Virginia Tuckwell, Autor Fecha de publicación: 2023 Artículo en la página: pp. 185-189 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antidepresivos de segunda generación, Ciclohexanoles, Trastorno depresivo mayor, Resistencia a los medicamentos. Resumen: The aim of this study was to evaluate the response to venlafaxine in patients with treatment-resistant depression during an extension phase of an open-label study of venlafaxine. After completing the initial 8 weeks of the study, patients could continue venlafaxine treatment for an additional period of up to 10 months. Efficacy results are given for 149 patients with treatment-resistant depression. Link: ./index.php?lvl=notice_display&id=31123 [artículo] Sustained response to open-label venlafaxine in drug-resistant major depression [texto impreso] / Isaac Schweitzer, Autor ; Graham AO, Burrows, Autor ; Virginia Tuckwell, Autor . - 2023 . - pp. 185-189. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2001 - Vol. 21 - No. 2 (Abril) . - pp. 185-189 Palabras clave: Antidepresivos de segunda generación, Ciclohexanoles, Trastorno depresivo mayor, Resistencia a los medicamentos. Resumen: The aim of this study was to evaluate the response to venlafaxine in patients with treatment-resistant depression during an extension phase of an open-label study of venlafaxine. After completing the initial 8 weeks of the study, patients could continue venlafaxine treatment for an additional period of up to 10 months. Efficacy results are given for 149 patients with treatment-resistant depression. Link: ./index.php?lvl=notice_display&id=31123

---

1 (1 - 1 / 1)